TECH BUYER Aug 2022 - IDC MarketScape - Doc # EUR148080022
IDC MarketScape: European Enterprise Medical Imaging 2022 Vendor Assessment
This IDC MarketScape assesses the main enterprise medical imaging (EMI) solutions currently available in the European market. This study provides healthcare providers with insight into EMI suppliers' capabilities and strategies that are designed to support them in their digital transformation journeys. Investing in EMI has become a key component of European healthcare organizations' digital strategies.
"The increasing adoption of EMI is primarily due to the need to unite images and data from multiple 'ologies' and create a patient-centric workflow. Optimizing the imaging workflow helps to balance high-quality care and efficiency. Also, integrating AI technologies into medical imaging devices to automate and standardize complex diagnostic procedures paves the way for more personalized care and precision health," said Adriana Allocato, research manager, IDC Health Insights.
"Adopting an end-to-end approach to patient imaging enables the long-awaited 360-degree view of patients and their health journeys, driving benefits in terms of care quality and experiences. EMI drives resilience, efficiency, and innovation into established care practices and operational aspects. Most importantly, it scales multidisciplinary and collaborative care delivery models and expands the use of intelligence-driven diagnostic tools across the healthcare ecosystem," said Silvia Piai, research director and European head, IDC Health Insights.
IDC Health Insights: European Digital Hospital , IDC Health Insights: European Healthcare Digital Strategies
Hyland Software, Inc., Sectra AB, FUJIFILM Holdings Corporation, Change Healthcare LLC, General Electric Company, Agfa-Gevaert N.V., Koninklijke Philips N.V.
Analytic applications, Cognitive/artificial intelligence, Content management, Printers, Technology buyer
List of Tables
List of Figures
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.